J
JW Shinyak Corp
KOSDAQ:067290
JW Shinyak Corp
KOSDAQ:067290
Price:
2 010
KRW
4.52%
Market Closed
Market Cap:
₩112.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
JW Shinyak Corp
KOSDAQ:067290
|
KR |
|
Alan Allman Associates SA
PAR:AAA
|
FR |
|
M
|
Minfeng Special Paper Co Ltd
SSE:600235
|
CN |
|
D
|
Dataproces Group A/S
CSE:DATA
|
DK |
|
Incap Ltd
BSE:517370
|
IN |
|
Mistras Group Inc
NYSE:MG
|
US |
|
S
|
Sanwayuka Industry Corp
TSE:4125
|
JP |
|
LICT Corp
OTC:LICT
|
US |
|
Q
|
Quipt Home Medical Corp
XTSX:QIPT
|
US |
|
T
|
Tanco Holdings Bhd
KLSE:TANCO
|
MY |
|
P
|
Partner Communications Company Ltd
TASE:PTNR
|
IL |
|
SKY Perfect JSAT Holdings Inc
TSE:9412
|
JP |
|
Sphere 3D Corp
NASDAQ:ANY
|
CA |
|
Super Retail Group Ltd
ASX:SUL
|
AU |
|
Taiwan Pelican Express Co Ltd
TWSE:2642
|
TW |
Relative Value
The Relative Value of one JW Shinyak Corp stock under the Base Case scenario is hidden KRW. Compared to the current market price of 2 010 KRW, JW Shinyak Corp is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JW Shinyak Corp Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
JW Shinyak Corp Competitors
JW Shinyak Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
J
|
JW Shinyak Corp
KOSDAQ:067290
|
112.3B KRW | 1.5 | 11.1 | 21.6 | 33.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
